BC Extra | Jul 2, 2015
Financial News

Kiadis raises EUR 32.7M in IPO

Kiadis Pharma B.V. (Euronext:KDS) raised EUR 32.7 million ($36.2 million) through the sale of 2.6 million shares at EUR 12.50 in an IPO underwritten by Kempen; KBC Securities; and Peel Hunt. The IPO price values...
Items per page:
1 - 1 of 1